1.Study of relationship between Pre-S1 antigen and hepatic function in patients with chronic hepatitis B
Clinical Medicine of China 2016;32(5):424-425
Objective To investigate the relationship between Pre-S1 antigen and hepatic function of the patients with chronic hepatitis B.Methods Serum samples of 300 cases with chronic hepatitis B patients were collected,Pre-S1 antigen and alanine aminotransferase (ALT),aspartate aminotransferase (AST) were checked,and the correlation were analyzed.Results Among 300 cases,patients with positive Pre-S1 antigen were 58.33%(175/300).In patients with positive Pre-S1 antigen,the abnormal ALT(>40 U/L) detection rate was 78.75% (138/175),the abnormal AST(>40 U/L) detection rate was 77.17% (136/175),Pre-S1 antigen negative patients ALT abnormal detection rate was 51.20% (64/125),AST anomaly detection rate was 42.40% (53/125).There was significant difference between two groups(x2 =2.875,5.223;P<0.05).Conclusion In patients with chronic hepatitis B,Pre-S1 antigens can be used as a marker of hepatitis B virus infection,copy and hepatic cell injury.
2.Effect of oral administration of guanxin II decoction on coronary blood flow and cardiac systolic/diastolic function in healthy males.
Hong-quan GAN ; Xi HUANG ; Xin-qiao TIAN ; Yongsheng ZHU ; Shanhong ZHANG ; Jun LI ; Ping REN ; Qibing MEI
Chinese Journal of Integrated Traditional and Western Medicine 2004;24(9):785-789
OBJECTIVETo observe the effects of oral administration of guanxin II decoction (GX II) on cardiovascular function, especially on the dynamics of coronary blood flow in healthy males.
METHODSChanges of heart rate, diastolic pressure, systolic pressure, left ventricular ejection fraction (LVEF), E peak, A peak, E/A value of mitral flow, diastolic peak velocity (Vmax) and diastolic flow velocity time integrals (VTI) of left anterior descending coronary artery (LAD) in 11 healthy male subjects were measured before and after oral administration of GX II, using non-invasive echocardiogram.
RESULTSCompared with those before GX II administration, the changes after administration in heart rate, systolic pressure, diastolic pressure, LVEF, E peak, A peak and E/A value, were insignificantly different (P>0.05), but the Vmax and VTI significantly increased at 30 min, 60 min, 90 min and 120 min after GX II administration (P<0.05).
CONCLUSIONTo increase the coronary blood flow is possibly one of the mechanisms of GX II in treating coronary heart disease and angina pectoris.
Adolescent ; Adult ; Blood Flow Velocity ; drug effects ; Coronary Circulation ; drug effects ; Coronary Disease ; drug therapy ; Coronary Vessels ; drug effects ; ultrastructure ; Diastole ; drug effects ; Drugs, Chinese Herbal ; pharmacology ; Echocardiography ; Heart Rate ; drug effects ; Humans ; Male ; Middle Aged ; Systole ; drug effects ; Vasodilator Agents ; pharmacology ; Ventricular Function, Left ; drug effects